Depression is considered as one of the most common forms of psychiatric disorders. Depression is a disabling condition that not only affects the health and wellbeing of the patient but also adversely affects the family. Every year the prevalence of depression is rapidly increasing across the world. Anxiety is a reaction to stress. Normally, it is characterized as an urge to deal with adverse situations. However, extreme levels of anxiety may be called anxiety disorder. This disorder is characterized on the basis of the behavior of the individual. The major forms of anxiety disorders include obsessive-compulsive disorder, phobias, post-traumatic stress disorder, and panic disorder.

The causes of both the above disorders are not comprehensively established. The several causes of depression and anxiety disorders include lower level of some neurotransmitters, genetic inheritance, psychological reasons, emotional upheavals, and also due to environmental, spiritual, and social factors. There is no uniform pattern of treatment for patients suffering with depression or anxiety disorders. Any treatment that works on one patient may not be as effective on another.

Thus the treatments for depression and anxiety disorders are customized. Out of the various modes of therapies available for depression, psychotherapy is the most common. Psychodynamic therapy, behavioral therapy, and interpersonal therapy are the major types of psychotherapies used for treating depression. The various medications used in treatment for depression are selective serotonin reuptake inhibitors, dual-action antidepressants, atypical antidepressants, mood stabilizers and anticonvulsants, tricyclic antidepressants, and monoamine oxidase inhibitors.

In addition, medications for anxiety are found to be substantially helpful in treating patients with anxiety disorders whose daily function is being disturbed due to the illness. The medications that are often used for treating anxiety disorders are benzodiazepines and antidepressants. Furthermore, in some cases, electroconvulsive therapy is also found to be useful in severe cases. In addition to the above therapeutic methods, lifestyle changes are also prescribed to the patients. The other less often and/or auxiliary methods of treating depression and anxiety disorders are music therapy, botanical medicines, mind-body practice, naturopathic medicine, and homeopathy.

The major antidepressants and anti-anxiety drug manufacturers include pharmaceutical companies such as AstraZeneca, Eli Lilly and Company, Johnson and Johnson, Pfizer, Inc., Sanofi-Aventis, Merck and Company, Inc., GlaxoSmithKline, and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...

According to a new market report published by Transparency Market Research "Seed Treatment (Insecticides, Fungicides, Other Chemical and Nonchemical Treatment) Market For Corn, Soybean, Wheat, Canola, Cotton and Others - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018,"  the global seed treatment market was valued at USD 2.43 billion in 2011 and is expected to reach USD 4.45 billion by 2018, growing at a CAGR of 9.2% from 2012 to 2018.

The global demand of seed treatment has been primarily driven by the growth of the commercial seeds (conventional and bio-seeds) market. Increasing global farming and reduction in arable land has generated the need for high yield productivity, further boosting the market for seed treatment. Increasing input cost of seeds and technological developments in agriculture are also expected to drive the demand for seed treatment. However, environmental concerns regarding the toxicity of chemicals used in insecticides, fungicides and other chemical treatments are expected to inhibit the market growth.

Insecticides dominated the seed treatment market and accounted for 52.5% of the total market revenue in 2011. Insecticides were followed by fungicides which accounted for 34.9% of the total market in 2011. Nonchemical treatment, which is generally done using biological agents, is expected to be the fastest growing treatment, at an estimated CAGR of 9.9% from 2012 to 2018.

Corn was the most dominant crop for seed treatment, accounting for 34.7% of the global revenues in 2011. Corn was followed by soybean, wheat canola and cotton. Canola is expected to be the fastest growing crop requiring seed treatment, at a CAGR of 9.6% from 2012 to 2018.

North America was the leading market for seed treatment and accounted for 42.8% of the global market in 2011; North America was followed by Latin America sharing 24.2% of the global market for the same year. Asia Pacific is expected to be the fastest growing market for seed treatment at a CAGR of 10.2% from 2012 to 2018. Growing awareness regarding the advantages of treating seeds coupled with government initiatives in countries such as China and India is expected to drive the seed treatment demand in Asia Pacific.

The global market for seed treatment is highly concentrated with the top four companies accounting for more than 80% of the total market in 2011. Syngenta and Bayer CropScience together accounted for more than 60% of the total market in 2011. Some of the other companies operating in the global seed treatment market include Monsanto, BASF Agriculture Solutions, DuPont, Chemtura, Nufarm etc.

» Read More...

Geothermal energy is a type of heat energy that is produced in the earth’s core. This energy is utilized in a wide range of applications from power stations to simple pumping systems. Geothermal energy is considered as a renewable source of energy since the water which is captured in the form of heat while extracting geothermal energy is continuously replenished by rainfall and again the heat generated from it can be used. A major concentration of geothermal energy on the planet is in the area bordering the Pacific Ocean and is called the Ring of Fire. 

There are two types of geothermal systems – hydrothermal and hot rock or enhanced geothermal systems. The most important type of geothermal energy is hydrothermal energy which is most widely used for generating electricity.

Increasing concerns regarding energy security, economic growth in developing markets, rising costs of fossil fuels, several incentives given by European countries, new technologies like binary technology, which can use even moderate temperatures to generate a decent amount of electricity, are some of the major drivers that are significantly fuelling this market.  

The major impediments which this industry faces include initial financing of large scale projects, resource development risks like failure of drilling wells and insufficient productivity, lack of skilled labor to work on the projects, issues related to drilling rigs and market and network issues like proximity to the market and network capital costs. Also, there are some environmental problems in producing geothermal energy like release of hydrogen sulfide and disposal of toxic geothermal fluids while extraction. 

Challenges to this industry are carrying out efficient programs for land leasing where reserves of geothermal energy are located, better drilling assistance in terms of accurate positioning of the site and its viability, and significant financial support needed to establish the plants at the desired locations.

The United States of America has the largest amount of installed capacity and is succeeded by Philippines, Indonesia, Mexico, and Italy. Currently there are over 150 projects under development in the U.S.. On the other hand, China is the largest direct user of geothermal energy followed by the United States, Sweden, and Turkey.

Some of the players of this sector include  Ormat Technologies, Chevron, Calpine, US Geothermal, Raser Technologies, AltaRock Energy, Enel Green Power North America, Gradient Resources, Islandsbanki, MidAmerican Energy Holdings Company., Nevada Geothermal Power Inc. , Ram Power, Terra-Gen Power, ThermaSource, Cyrq Energy, Scientific Drilling International (SDI), and Toshiba International Corporation.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

North America 

Asia Pacific 

Europe

Rest of the World  

This report provides comprehensive analysis of 

Market growth drivers 

Factors limiting market growth

Current market trends 

Market structure

Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

» Read More...